Translating the biology of regulatory T cells into transformational medicines for patients.
Our targeted, autologous Treg cell therapies for progressive multiple sclerosis and other serious autoimmune diseases stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in affected tissues.
We are industry experts and scientific pioneers working together to bring an entirely new approach to the treatment of autoimmune disease.
We’re pushing the frontiers of science together, and we take joy in our work. We value people and believe in limitless possibilities, the power of diversity and the importance of kindness.
Nagesh Mahanthappa Ph.D., M.B.A., and Valerie Odegard, Ph.D., bring significant immunobiology, entrepreneurship, and business development experience to Abata